772032008: Burosumab (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Monoclonal antibody\Monoclonal immunoglobulin G (substance)\Burosumab

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\...

\Plasma protein (substance)\Immunoglobulin\Immunoglobulin structure (substance)\Entire immunoglobulin (substance)\Immunoglobulin isotype\Immunoglobulin G (substance)\Monoclonal immunoglobulin G (substance)\Burosumab

\Antibody\Monoclonal antibody\Monoclonal immunoglobulin G (substance)\Burosumab

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\...

\Plasma protein (substance)\Immunoglobulin\Immunoglobulin structure (substance)\Entire immunoglobulin (substance)\Immunoglobulin isotype\Immunoglobulin G (substance)\Monoclonal immunoglobulin G (substance)\Burosumab

\Antibody\Monoclonal antibody\Monoclonal immunoglobulin G (substance)\Burosumab

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3708082013 Burosumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3708083015 Burosumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

5526101000241114 burosumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Burosumab	Is a	Monoclonal immunoglobulin G (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing burosumab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Burosumab	Inferred relationship	Some	1
Burosumab-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Burosumab	Inferred relationship	Some	1
Product containing only burosumab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Burosumab	Inferred relationship	Some	1
Product containing only burosumab in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Burosumab	Inferred relationship	Some	1
Product containing precisely burosumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Burosumab	Inferred relationship	Some	1
Product containing precisely burosumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Burosumab	Inferred relationship	Some	1
Product containing precisely burosumab 30 milligram/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Burosumab	Inferred relationship	Some	1
Product containing precisely burosumab 30 milligram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Burosumab	Inferred relationship	Some	1
Product containing precisely burosumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Burosumab	Inferred relationship	Some	1
Product containing precisely burosumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Burosumab	Inferred relationship	Some	1

This concept is not in any reference sets